Abstract

Although the probability of pancreatic cystic neoplasms (PCNs) being detected is raising year by year, their differential diagnosis and individualized treatment are still a challenge in clinical work. PCNs are tumors containing cystic components with different biological behaviors, and their clinical manifestations, epidemiology, imaging features, and malignant risks are different. Some are benign [e.g., serous cystic neoplasms (SCNs)], with a barely possible that turning into malignant, while others display a low or higher malignant risk [e.g., solid pseudopapillary neoplasms (SPNs), intraductal papillary mucinous neoplasms (IPMNs), and mucinous cystic neoplasms (MCNs)]. PCN management should concentrate on preventing the progression of malignant tumors while preventing complications caused by unnecessary surgical intervention. Clinically, various advanced imaging equipment are usually combined to obtain a more reliable preoperative diagnosis. The challenge for clinicians and radiologists is how to accurately diagnose PCNs before surgery so that corresponding surgical methods and follow-up strategies can be developed or not, as appropriate. The objective of this review is to sum up the clinical features, imaging findings and management of the most common PCNs according to the classic literature and latest guidelines.

Highlights

  • In recent years, the diagnostic rate of pancreatic cystic neoplasms (PCNs) has risen and still keeps an increasing trend

  • intraductal papillary mucinous neoplasms (IPMNs) approximately 21% to 33%, mucinous cystic neoplasms (MCNs) account for 10% to 45%, solid pseudopapillary neoplasms (SPNs) account for less than 10%, and serous cystic neoplasms (SCNs) account for 32% to 39% of all PCNs in the Western Hemisphere

  • There was a national survey report from Korea shows that IPMNs approximately 41%, MCNs approximately 25.2%, SPNs approximately 18.3%, SCNs approximately 15.2%, and others account for 0.3% of PCNs [7, 8]

Read more

Summary

Frontiers in Oncology

The probability of pancreatic cystic neoplasms (PCNs) being detected is raising year by year, their differential diagnosis and individualized treatment are still a challenge in clinical work. PCNs are tumors containing cystic components with different biological behaviors, and their clinical manifestations, epidemiology, imaging features, and malignant risks are different. PCN management should concentrate on preventing the progression of malignant tumors while preventing complications caused by unnecessary surgical intervention. The challenge for clinicians and radiologists is how to accurately diagnose PCNs before surgery so that corresponding surgical methods and follow-up strategies can be developed or not, as appropriate. The objective of this review is to sum up the clinical features, imaging findings and management of the most common PCNs according to the classic literature and latest guidelines

INTRODUCTION
THE MAJOR PANCREATIC CYSTIC NEOPLASMS
Intraductal Papillary Mucinous Neoplasm
Mucinous Cystic Neoplasm
Entire pancreas
Branching papillae with myxoid stroma Low or medium
Solid Pseudopapillary Neoplasm
Serous Cystic Neoplasms
IMAGING DIAGNOSIS AND PRECISION IMAGING
The CT and MR Manifestations of IPMN
The CT and MR Manifestations of MCN
The CT and MR Manifestations of SCN
CT and MR Manifestations of SPN
Tumor Markers
Molecular Markers
THE MANAGEMENT OF PCNS
CONCLUSIONS
Findings
AUTHOR CONTRIBUTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call